AMILI is a company at the forefront of microbiome research and healthcare innovation, aiming to help us reshape the way we think about our gut health.
As Asia’s first and only gut microbiome transplant bank, AMILI is on a mission to build the world’s largest multi-ethnic microbiome database, focusing specifically on the diverse populations of Southeast Asia.
On The Right Business, Hongbin Jeong speaks with Zat, Editor-in-Chief, The Peak Singapore to find out more.

The Big Story: Trump’s prime-time address on Iran - Victory speech or unfinished war?
19:57

Wealth Tracker: If investors aren’t selling US assets, where is the ‘Sell America’ trade happening?
18:10

What's Trending: China's laser highways are real… and Gmail is finally letting you change your cringe email
16:32